Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savitri Krishnamurthy

Showing results (211-220 of 262) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|May 29, 2015
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisTamer M Fouad, Takahiro Kogawa, Diane D Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Plos One|September 25, 2018
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer CenterTamer M Fouad, Naoto T Ueno, Robert K Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Cancer Immunology Research|May 6, 2017
4-1BB-Enhanced Expansion of CD8<sup>+</sup> TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8<sup>+</sup> T CellsMichiko Harao, Marie-Andrée Forget, Jason Roszik, et al.
JAMA Network Open|September 14, 2023
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical TrialHelen M Johnson, Heather Lin, Yu Shen, et al.
JAMA Oncology|March 28, 2025
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical TrialHenry M Kuerer, Vicente Valero, Benjamin D Smith, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Plos One|July 25, 2015
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsEvan N Cohen, Hui Gao, Simone Anfossi, et al.
Annals of Surgical Oncology|August 27, 2013
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?Elizabeth Fitzsullivan, Sara A Lari, Benjamin Smith, et al.
Pageof 27

Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|May 29, 2015
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisTamer M Fouad, Takahiro Kogawa, Diane D Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Plos One|September 25, 2018
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer CenterTamer M Fouad, Naoto T Ueno, Robert K Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Ductal carcinoma in situ: state of the science and roadmap to advance the fieldHenry M Kuerer, Constance T Albarracin, Wei T Yang, et al.
Cancer Immunology Research|May 6, 2017
4-1BB-Enhanced Expansion of CD8<sup>+</sup> TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8<sup>+</sup> T CellsMichiko Harao, Marie-Andrée Forget, Jason Roszik, et al.
JAMA Network Open|September 14, 2023
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical TrialHelen M Johnson, Heather Lin, Yu Shen, et al.
JAMA Oncology|March 28, 2025
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical TrialHenry M Kuerer, Vicente Valero, Benjamin D Smith, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Plos One|July 25, 2015
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsEvan N Cohen, Hui Gao, Simone Anfossi, et al.
Annals of Surgical Oncology|August 27, 2013
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?Elizabeth Fitzsullivan, Sara A Lari, Benjamin Smith, et al.
Pageof 27